期刊文献+

消栓颗粒治疗颈动脉粥样硬化的安全性研究

Safety bolt granule treatment of carotid artery atherosclerosis
下载PDF
导出
摘要 目的分析消栓颗粒治疗颈动脉粥样硬化斑块的效果及安全性。方法选择2015年1月—2017年1月我院神经内科门诊以及住院部诊治的颈动脉粥样硬化斑块患者150例,随机分为观察组和对照组各75例,对照组给予常规西医(阿司匹林肠溶片+阿托伐他汀钙片)治疗,观察组在西医治疗的基础上加用消栓颗粒,分析2组患者的临床效果和安全性。结果 2组患者均无出现药物的相关副作用,而加用消栓颗粒治疗的观察组中颈动脉内径、颈动脉中层内膜厚度、斑块面积等指标恢复均优于对照组(P<0.05)。结论加用消栓颗粒治疗颈动脉粥样硬化斑块的临床效果较好,安全可靠,值得推广应用。 Objective Observation and analysis of bolt on treatment of carotid atherosclerotic plaques, efficacy, and safety. Methods Choose between January 2017 and January 2015 in our nerve internal medicine outpatient and the inpatient treatment of 150 patients with carotid atherosclerotic plaques were randomly divided into observation group and control group, 75 cases in each group, control group given conventional western medicine (Aspirin Enteric-coated Tablets + Atorvastatin calcium tablets) treatment, the observation group on the basis of western medicine combined with bolt particles, analysis of two groups of patients with clinical efficacy and safety. Results Two groups of patients without any drug related side effects, and add a bolt on treatment of the carotid artery diameter in the observation group, the thickness of the carotid artery middle lining, plaque area of indicators such as recovery were better than the control group (P〈0.05). Conclusion combined with bolt elimination particles in the treatment of carotid atherosclerotic plaques effect is good, safe and reliable, is worth popularization and application.
出处 《基层医学论坛》 2017年第16期2026-2027,共2页 The Medical Forum
基金 广西贵港市科学研究与技术开发计划项目(1504018)
关键词 颈动脉粥样硬化斑块 阿司匹林肠溶片 阿托伐他汀钙片 消栓颗粒 Chuan elimination particles Aspirin enteric-coated tablets Atorvastatin calcium tablets Carotid atherosclerotic plaques
  • 相关文献

参考文献4

二级参考文献29

  • 1孙公平,朱新旺,王亚杰.同型半胱氨酸与动脉粥样硬化性血管病[J].中国心血管杂志,2006,11(1):68-70. 被引量:15
  • 2董震海,吴素芳,于晓静.他汀类药物临床应用研究进展[J].中国医刊,2006,41(5):50-51. 被引量:11
  • 3杨瑞雪,张继东,张维东,贾青.益肾活血胶囊对同型半胱氨酸血症大鼠生长因子的影响[J].山东大学学报(医学版),2007,45(4):412-415. 被引量:11
  • 4Clement DL, Boccalon H, Dormandy J, et al. A clinical approach to the management of the patients with coronary and / or carotid artery disease who presents with leg ischaemia[J]. Int Angiol, 2000,19: 97-125.
  • 5Yamasaki Y, Kodama M, Nishizawa H, et al, Carotid intima-media thickness in Japanese type 2 disbetic subjects: predictors of progression and relationship with incident coronary heart disease [J]. Disbetes Care ,2000,23 : 1310-1315.
  • 6Kallikazaros I Tsioufis C, Sideris S, et al. Carotid artery disease as a marker for the presence of severe coronary, artery disease in patients evaluated for chest pale[J], Stroke, 1999,30:1002-1007.
  • 7Kim HY, Kim CJ, Rho TH, et al. Transesophageal echocardiographic detection of thoracic aortic plaque could noninvasively predict significant obstractive coronary artery disease[J].J Intern Med ,1999,14:20-26.
  • 8Sutton TK,Alcocm HG,Wolfson SK,et al.Prediotors of carotid stenosis in older adults with and without isolated systolic hypertension[J].Stroke,1993,24:355-359.
  • 9Bomithon KP,Vaviver J.Anne T,et al.Early cartid atherosclerosis in healthy middle-aged women:a follow-up study[J].Stroke,1993,24:1837-1842.
  • 10Salonen JT,Salonen R.Ultrasound B-mode imaging in observational studies of atherosclerotic progression[J].Circulation,1993,87(suppl 2):56-65.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部